NEU 0.15% $13.13 neuren pharmaceuticals limited

Yes Wizza, indeed there are far more variables however...

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    Yes Wizza, indeed there are far more variables however Trofinetide (or should I say Daybue) reduces cytokines or the inflammatory molecules, following brain injury so physiologically it has to have a positive affect on that alone. Too valuable of an asset to gather cob webs on the shelf as I've previously said. Nice to have options though
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.